Leap Therapeutics Market Risk Adjusted Performance
| LPTXDelisted Stock | | | USD 2.05 1.44 236.07% |
Technical inputs supporting the Market Risk Adjusted Performance indicator for Leap Therapeutics are shown here. Additional screening context is available through
Equity Screeners. Leap Therapeutics has a market cap of 116.14 M, ROE of -1.84%. Review
Correlation Analysis for broader portfolio context. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
Leap Therapeutics has current Market Risk Adjusted Performance of
-1.12.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -1.12 | |
| ER[a] | = | Expected return on investing in Leap Therapeutics |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Leap Therapeutics is rated
below average in market risk adjusted performance among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors .
Other Technical Indicators